USPTO 2015–2025 USPTO PatentsView US Corporation

Roche Diagnostics Operations, Inc.

USPTO PatentsView assignee record - 654 granted patents across 111 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Roche ranks #690 of 49,997 tracked US assignees by granted-patent volume, with 654 patents across 111 technology areas.

#690
of 49,997 US assignees by volume
Top 3%
by Innovation Score (62.0/100)
13.5
avg claims per patent
-15%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R690 · US Corporation #690 · 654 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MID 654 grants
  • TOP-DECILE #690/49,997
  • PHOTO-FINISH pSemi
  • CPC-WIDE G01N · 111 areas
  • INNOV-STRONG 62.0/100
  • CLAIMS-RICH 13.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -15% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: pSemi Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Roche

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Roche's Innovation Score is 62.0/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Roche's grant cadence moved

Between 2020–2024, Roche Diagnostics Operations, Inc. received 280 grants versus 331 in 2015–2019 (-15% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2015 at 101 grants and bottomed in 2020 at 39. Lead class G01N accounts for 73.7% of the portfolio across 111 subclasses. Volume neighbours: Inventec Corporation (#685) and Incyte Corporation (#693).

Roche's three-year grant acceleration

From 2019–2021 to 2022–2024, Roche Diagnostics Operations, Inc. moved from 179 to 176 grants (0.98x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,226. See the growth leaderboard.

Who files at Roche's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Roche holds 654 patents at rank #689, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Roche

By rank, the assignees closest to #689 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Roche's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Roche, neither rank-band nor same-CPC leaders (those blocks stay above).

Roche's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

20406080100120 20152016201720182019202020212022202320242025 43
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Roche Diagnostics Operations, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 101 15.4%
2016 48 7.3%
2017 49 7.5%
2018 58 8.9%
2019 75 11.5%
2020 39 6.0%
2021 65 9.9%
2022 55 8.4%
2023 50 7.6%
2024 71 10.9%
2025partial year 43 6.6%

Which technologies does Roche Diagnostics Operations, Inc. patent most?

Top 15 of 111 technology areas

Where it ranks

Overall rank by patents

#690

of 49,997 tracked assignees

Innovation Score

62.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Roche Diagnostics Operations, Inc.'s patent record in context - here's where to go next.

  • Roche Diagnostics Operations, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 73.7% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #690 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Roche Diagnostics Operations, Inc. against Inventec Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 62.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.